We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Mettler-Toledo International Inc.’s (MTD - Free Report) first-quarter 2017 results beat the Zacks Consensus Estimate on earnings and revenues. While adjusted earnings per share (EPS) of $3.34 beat the consensus mark by 8.4%, revenues of $594.6 million beat the same by 4.3%.
The better-than-expected results were driven by strong growth across all product lines and regions. The company’s growth initiatives - Field Turbo investments, marketing initiatives, Spinnaker sales and new product launches continued delivering positive results. Margin and productivity initiatives also bode well.
Overall, we remain positive about Mettler-Toledo’s leading market position, focus on product development and cost reduction, sales and marketing efforts and operational excellence programs. The company has had an impressive run on the bourse over the last one year. It gained roughly 45.5%, higher than the Zacks Instruments - Scientific industry’s addition of almost 21%.
However, seasonality, volatility in emerging market growth, foreign exchange risk and business concentration in China remain major concerns.
Let’s check out the numbers:
Revenues
Net revenue was down 16.2% sequentially but up 10.2% on a year-over-year basis. The year-over-year improvement was driven by strengths across all the segments and contribution from the Troemner acquisition. Laboratory, Industrial and Food Retail increased 13%, 12% and 8%, respectively.
Operating Results
Gross margin was 57.7%, down 131 basis points (bps) sequentially but up 210 bps year over year. The year-over-year increase was driven by pricing and productivity gains in plants and Service business. Pro-forma operating margin was 21.4%, up 680 basis points (bps) sequentially and 250 bps year over year.
Non-GAAP net income was $88.9 million or $3.34 per share compared with $67.4 million or $2.46 per share a year ago. GAAP net income was $92.5 million or $3.48 per share compared with $65.7 million or $2.40 per share a year ago.
At the end of the first quarter, cash and cash equivalents balance was $164.9 million compared with $158.7 million in the previous quarter. Long-term debt was $944.2 million compared with $875.1 million in the previous quarter.
The company generated $67.6 million in cash from operating activities and spent $21 million on capex. During the quarter, the company returned nearly $125 million to shareholders by repurchasing shares.
Outlook
For the second quarter of 2017, Mettler-Toledo expects local currency sales to grow approximately 8% to 9%. Adjusted EPS is expected to grow 20% to 21% to $3.85 to $3.90. The Zacks Consensus Estimate for EPS is pegged at $3.60.
Zacks Rank and Stocks to Consider
Mettler-Toledo currently has a Zacks Rank #2 (Buy). Other stocks worth considering in the broader technology sector include Alphabet Inc. (GOOGL - Free Report) , Monolithic Power Systems, Inc. (MPWR - Free Report) and Internap Corp. . While Alphabet sports a Zacks Rank #1 (Strong Buy), Monolithic Power and Internap carry a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term expected earnings per share growth rates for Alphabet, Internap and Monolithic Power are 16.7%, 3% and 17%, respectively.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Mettler-Toledo (MTD) Beats Q1 Earnings, Revenue Estimates
Mettler-Toledo International Inc.’s (MTD - Free Report) first-quarter 2017 results beat the Zacks Consensus Estimate on earnings and revenues. While adjusted earnings per share (EPS) of $3.34 beat the consensus mark by 8.4%, revenues of $594.6 million beat the same by 4.3%.
The better-than-expected results were driven by strong growth across all product lines and regions. The company’s growth initiatives - Field Turbo investments, marketing initiatives, Spinnaker sales and new product launches continued delivering positive results. Margin and productivity initiatives also bode well.
Overall, we remain positive about Mettler-Toledo’s leading market position, focus on product development and cost reduction, sales and marketing efforts and operational excellence programs. The company has had an impressive run on the bourse over the last one year. It gained roughly 45.5%, higher than the Zacks Instruments - Scientific industry’s addition of almost 21%.
However, seasonality, volatility in emerging market growth, foreign exchange risk and business concentration in China remain major concerns.
Let’s check out the numbers:
Revenues
Net revenue was down 16.2% sequentially but up 10.2% on a year-over-year basis. The year-over-year improvement was driven by strengths across all the segments and contribution from the Troemner acquisition. Laboratory, Industrial and Food Retail increased 13%, 12% and 8%, respectively.
Operating Results
Gross margin was 57.7%, down 131 basis points (bps) sequentially but up 210 bps year over year. The year-over-year increase was driven by pricing and productivity gains in plants and Service business. Pro-forma operating margin was 21.4%, up 680 basis points (bps) sequentially and 250 bps year over year.
Non-GAAP net income was $88.9 million or $3.34 per share compared with $67.4 million or $2.46 per share a year ago. GAAP net income was $92.5 million or $3.48 per share compared with $65.7 million or $2.40 per share a year ago.
Mettler-Toledo International, Inc. PE Ratio (TTM)
Mettler-Toledo International, Inc. PE Ratio (TTM) | Mettler-Toledo International, Inc. Quote
Balance Sheet and Cash Flow
At the end of the first quarter, cash and cash equivalents balance was $164.9 million compared with $158.7 million in the previous quarter. Long-term debt was $944.2 million compared with $875.1 million in the previous quarter.
The company generated $67.6 million in cash from operating activities and spent $21 million on capex. During the quarter, the company returned nearly $125 million to shareholders by repurchasing shares.
Outlook
For the second quarter of 2017, Mettler-Toledo expects local currency sales to grow approximately 8% to 9%. Adjusted EPS is expected to grow 20% to 21% to $3.85 to $3.90. The Zacks Consensus Estimate for EPS is pegged at $3.60.
Zacks Rank and Stocks to Consider
Mettler-Toledo currently has a Zacks Rank #2 (Buy). Other stocks worth considering in the broader technology sector include Alphabet Inc. (GOOGL - Free Report) , Monolithic Power Systems, Inc. (MPWR - Free Report) and Internap Corp. . While Alphabet sports a Zacks Rank #1 (Strong Buy), Monolithic Power and Internap carry a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term expected earnings per share growth rates for Alphabet, Internap and Monolithic Power are 16.7%, 3% and 17%, respectively.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>